Your browser is no longer supported. Please, upgrade your browser.
AZN AstraZeneca PLC daily Stock Chart
AZN [NYSE]
AstraZeneca PLC
Index- P/E67.74 EPS (ttm)0.82 Insider Own0.50% Shs Outstand2.62B Perf Week-0.66%
Market Cap144.86B Forward P/E21.62 EPS next Y2.56 Insider Trans0.00% Shs Float2.60B Perf Month2.67%
Income2.15B PEG3.51 EPS next Q0.53 Inst Own18.20% Short Float0.05% Perf Quarter3.98%
Sales25.70B P/S5.64 EPS this Y-39.70% Inst Trans-0.48% Short Ratio0.17 Perf Half Y12.17%
Book/sh4.66 P/B11.89 EPS next Y30.77% ROA3.60% Target Price56.65 Perf Year25.53%
Cash/sh2.34 P/C23.69 EPS next 5Y19.30% ROE17.80% 52W Range36.15 - 64.94 Perf YTD11.13%
Dividend1.40 P/FCF- EPS past 5Y1.00% ROI8.30% 52W High-14.68% Beta0.54
Dividend %2.53% Quick Ratio0.60 Sales past 5Y-1.70% Gross Margin80.30% 52W Low53.28% ATR1.55
Employees70600 Current Ratio0.80 Sales Q/Q7.80% Oper. Margin14.90% RSI (14)48.17 Volatility1.39% 2.97%
OptionableYes Debt/Eq1.61 EPS Q/Q481.10% Profit Margin8.40% Rel Volume0.54 Prev Close56.21
ShortableYes LT Debt/Eq1.28 EarningsJul 30 BMO Payout0.00% Avg Volume7.15M Price55.41
Recom1.60 SMA20-1.97% SMA501.37% SMA20010.99% Volume3,843,335 Change-1.42%
Nov-22-19Initiated SVB Leerink Outperform
Oct-25-19Upgrade Liberum Hold → Buy
Apr-02-19Downgrade UBS Neutral → Sell
Feb-05-19Initiated Exane BNP Paribas Outperform
Jan-25-19Upgrade Shore Capital Hold → Buy
Dec-11-18Resumed Jefferies Hold
Oct-09-18Initiated Guggenheim Buy
Aug-16-18Downgrade Jefferies Buy → Hold
Mar-19-18Upgrade Jefferies Hold → Buy
Feb-06-18Reiterated Leerink Partners Mkt Perform $36 → $38
Feb-05-18Reiterated Bernstein Outperform $40 → $42
Jan-18-18Reiterated Leerink Partners Mkt Perform $33 → $36
Dec-29-17Upgrade JP Morgan Neutral → Overweight
Oct-16-17Upgrade Credit Suisse Neutral → Outperform
Sep-25-17Upgrade Exane BNP Paribas Neutral → Outperform
Sep-22-17Upgrade Bernstein Mkt Perform → Outperform
Sep-14-17Downgrade Liberum Buy → Hold
Sep-06-17Upgrade Natixis Bleichroeder Neutral → Buy
Aug-09-17Upgrade Investec Hold → Buy
Jul-28-17Downgrade Morgan Stanley Overweight → Equal-Weight
Aug-08-20 03:33AM  
Aug-07-20 02:01PM  
11:02AM  
08:02AM  
06:00AM  
05:42AM  
05:37AM  
05:36AM  
05:18AM  
Aug-06-20 09:23PM  
04:55PM  
09:53AM  
04:08AM  
Aug-05-20 04:29PM  
07:35AM  
Aug-04-20 10:22PM  
12:58PM  
09:56AM  
09:21AM  
Aug-03-20 01:47PM  
11:44AM  
09:52AM  
07:00AM  
03:24AM  
Aug-02-20 06:00PM  
08:14AM  
06:39AM  
Aug-01-20 06:49AM  
Jul-31-20 03:26PM  
12:44PM  
11:47AM  
10:36AM  
07:01AM  
07:00AM  
07:00AM  
06:48AM  
06:40AM  
Jul-30-20 04:44PM  
04:22PM  
04:03PM  
12:25PM  
12:16PM  
11:23AM  
09:47AM  
09:26AM  
09:00AM  
07:22AM  
07:00AM  
06:55AM  
05:55AM  
02:58AM  
02:35AM  
12:39AM  
Jul-29-20 06:06PM  
02:07PM  
12:57PM  
Jul-28-20 08:31PM  
05:36PM  
05:35PM  
02:36PM  
01:22PM  
12:00PM  
09:48AM  
07:19AM  
07:00AM  
06:23AM  
05:38AM  
Jul-27-20 09:05PM  
09:01PM  
07:57PM  
05:59PM  
05:46PM  
04:10PM  
02:29PM  
12:51PM  
10:57AM  
10:20AM  
07:57AM  
07:18AM  
06:47AM  
05:58AM  
04:33AM  
02:21AM  
02:00AM  
Jul-26-20 02:33PM  
06:46AM  
06:30AM  
Jul-25-20 12:01PM  
07:02AM  
05:37AM  
Jul-24-20 07:01PM  
04:18PM  
12:16PM  
10:52AM  
10:27AM  
08:49AM  
08:10AM  
06:46AM  
03:30AM  
02:14AM  
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR/Komboglyze, Onglyza, Qtern, Symlin, Xigduo/Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Tudorza/Eklira, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, and Symbicort Turbuhaler for respiratory diseases; Fluenz Tetra/FluMist Quadrivalen and Synagis for infection diseases; Movantik/Moventig, Seroquel IR/Seroquel XR, and Vimovo for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. The company serves primary care and specialty care physicians through distributors and local representative offices. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ASTRAZENECA PLC10% OwnerOct 07Buy19.00425,0008,075,00014,650,334Oct 09 04:53 PM